Page 10 - Genmark Diagnostics News Today

By Reuters Staff 3 Min Read ZURICH (Reuters) - Roche is filling a testing portfolio gap by buying U.S.-based GenMark Diagnostics in a $1.8 billion deal that the Swiss pharmaceuticals manufacturer said taps one of the fastest-growing diagnostics areas. FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd Wiegmann Basel-based Roche launched a cash offer for GenMark for $24.05 per share, a premium of 43% on GenMark’s Feb. ...

Search jobs 10-Mar-2021 Molecular Diagnostics Market Emerging Players with New Opportunities 2021 | Molecular Diagnostics Industry Trends, Scope, Growth, Size, Developing Technologies, and Regional Analysis till 2027 Pune, Maharashtra, India, March 10 2021 (Wiredrelease) Brandessence Market Research and Consulting Pvt ltd –:Global Molecular Diagnostics Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027.  An increa...

CARLSBAD, Calif. (AP) _ GenMark Diagnostics Inc. (GNMK) on Thursday reported a loss of...

Search jobs 16-Feb-2021 Influenza Diagnostics Market Study including Growth Factors, New Top Players, Competitive Analysis by regions from 2021 to 2027 Influenza Diagnostics Market Report Provides Future Development Possibilities By Key Players , Key Drivers, Competitive Analysis, Scope, Key Challenges Analysis. The Reports Conjointly Elaborate The Expansion Rate Of The Industry Supported The Highest CAGR And Global Analysis. This Report Providing An...

Data Bridge Market Research Adds “ Global Women’s Health Diagnostics Market – Industry Trends and Forecast to 2028” new report to its research database. The report spread No of pages : 350 No of Figures: 60 No of Tables: 220 in it. This comprehensive Global Women’s Health Diagnostics Market industry research report includes a brief on these trends that can help the organizations operating in the industry to understand the market and strategize for their business expansion accordingl...

Study Highlights Potential Clinical Value of ePlex® Blood Culture ID Panels Major teaching hospital in Grenoble, France demonstrates that ePlex BCID results could have modified antimicrobial treatment in 45% of patients CARLSBAD, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced today the publication of a manuscript in Frontiers in Cellular and Infection Microbiology t...

CARLSBAD, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its fourth quarter and full year earnings results after market close on Thursday, February 25, 2021. Management will hold a conference call to review the company's financial performance starting at 4:30 p.m. ET on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the GenMark Diagnostics, Inc. website ...

The company could be a potential acquisition target.

Gainers Ayala Pharmaceuticals (NASDAQ:AYLA) shares rose 61.99% to $21.06 during Thursday's regular session. The current volume of 576.7K shares is ...

Search jobs 08-Feb-2021 COVID-19 Detection Kits Market Size to Expand at Highest Revenue US$ 10.08 Billion with Growth Rate at 17.3% CAGR by 2027 Impact Analysis of Covid-19 The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters. COVID-19 is a viral infection which affects the resp...